High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD
Open Access
- 1 January 2009
- journal article
- research article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2009, 1-10
- https://doi.org/10.1155/2009/580450
Abstract
Intestinal alterations in IBD are triggered and maintained by an overexpression of proinflammatory cytokines. Additionally, increased immune activation has been found in the adjacent intestinal areas without displaying any apparent histological alterations, however, the regulatory environment is not well established. Biopsy specimens from patients with ulcerative colitis (UC) and Crohn's disease (CD), from both affected and unaffected areas, and also from a group of colonic biopsies from healthy controls, were included in our study. Cytokines and markers of mucosal damage were analyzed by real-time PCR, and some of the results confirmed by western-blot and ELISA. Levels of IFN, TNF, IL-6, IL-15, IL-18, and IL-23 were increased (above healthy controls) in both affected and unaffected areas from IBD. IL-1, IL-6, IL-12, and IL-27 were higher in affected areas compared to unaffected ones in UC but not CD. In general, a correlation was observed between mRNA levels of these cytokines and both iNOS and Granzyme B. SOCS-2 and SOCS-3 were also increased in the affected areas. In conclusion, the unaffected areas from IBD show increased levels of a restricted set of cytokines that may exert immune activating roles in these areas without being able to trigger tissue damage.Keywords
Funding Information
- Instituto de Salud Carlos III (PI020895, 02/3068, VA057/04, SAN1052-VA02/05, AP2002-1696)
This publication has 23 references indexed in Scilit:
- Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in miceInternational Immunology, 2008
- Interleukin 18 maintains a long-standing inflammation in coeliac disease patientsClinical and Experimental Immunology, 2006
- STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit miceGut, 2006
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitisBiochemical and Biophysical Research Communications, 2005
- Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA MicroarraysPLoS Medicine, 2005
- Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2005
- Defining the roles of perforin, Fas/FasL, and tumour necrosis factor in T cell induced mucosal damage in the mouse intestineGut, 2002
- Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phaseThe Esophagus, 2002
- Crohn's diseaseThe Lancet, 2002